Adenosine inhibits collagen and protein synthesis in cardiac fibroblasts role of a(2b) receptors

Hypertension

Volumn 31, Issue 4, 1998, Pages 943-948

  Dubey, Raghvendra K ^a   Gillespie, Delbert G ^b   Jackson, Edwin K ^b  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

Adenosine; Collagen; Extracellular matrix; Fibroblasts; Hypertrophy; Myocardial infarction

Indexed keywords

1,3 DIPROPYL 8 (4 SULFOPHENYL)XANTHINE; 2 CHLOROADENOSINE; 2 [4 (2 CARBOXYETHYL)PHENETHYLAMINO]ADENOSINE 5' (N ETHYLCARBOXAMIDE); 8 (3,4 DIMETHOXYSTYRYL) 7 METHYL 1,3 DIPROPYLXANTHINE; 8 CYCLOPENTYLTHEOPHYLLINE; 9 (2 HYDROXY 3 NONYL)ADENINE; ADENOSINE; ADENOSINE A1 RECEPTOR; ADENOSINE A2B RECEPTOR; ADENOSINE KINASE INHIBITOR; COLLAGEN; DIPYRIDAMOLE; LEUCINE; PROLINE; RECEPTOR SUBTYPE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; COLLAGEN SYNTHESIS; EXTRACELLULAR MATRIX; FIBROBLAST; HEART; HEART INFARCTION; HEART MUSCLE FIBROSIS; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN SYNTHESIS INHIBITION; RAT; RECEPTOR BINDING;

EID: 0031924266     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.31.4.943     Document Type: Article

References (28)

1. Weber KT, Sun Y, Katwa LC, Cleutjens JP, Zhou G. Connective tissue and repair in the heart: potential regulatory mechanisms. Ann N Y Acad Sci. 1995;752:286-299.
2. Brilla CG, Maisch B, Weber KT. Myocardial collagen matrix remodeling in arterial hypertension. Eur Heart J. 1992;13(suppl D):24-32.
3. Somasundaram R, Schuppan D. Type I, II, III, IV, V, and VI collagens serve as extracellular ligands for the isoforms of platelet-derived growth factor (AA, BB and AB). J Biol Chem. 1996;271:26884-26891.
4. Zhu X, Assoian RK. Integrin-dependent activation of MAP kinase: a link to shape-dependent cell proliferation. Mol Biol Cell. 1995;6:273-282.
5. Iwami K, Ashizawa N, Do YS, Graf K, Hsueh WA. Comparison of Ang II with other growth factors on Egr-1 and matrix gene expression in cardiac fibroblasts. Am J Physiol. 1996;270:H2100-H2107.
6. 2B receptors. Circulation. 1997;96:2656-2666.
7. Butt RP, Laurent GJ, Bishop JE. Collagen production and replication by cardiac fibroblasts is enhanced in response to diverse classes of growth factors. Eur J Cell Biol. 1995;68:330-335.
8. Fisher SA, Absher M. Norepinephrine and angiotensin II stimulate secretion of TGF-beta by neonatal rat cardiac fibroblasts in vitro. Am J Physiol. 1995;268:C910-C917.
9. Jackson EK, Koehler M, Mi Z, Dubey RK, Tofovic SP, Carcillo JA, Jones GS. Possible role of adenosine deaminase in vaso-occlusive diseases. J Hypertens. 1996;14:19-29.
10. Mullane K, Bullough D. Harnessing an endogenous cardioprotective mechanism: cellular sources and sites of action of adenosine. J Mol Cell Cardiol. 1995;27:1041-1054.
11. Dubey RK, Mi Z, Gillespie DG, Jackson EK. Cyclic AMP-adenosine pathway inhibits vascular smooth muscle cell growth. Hypertension. 1996;28:765-771.
12. Dubey RK, Gillespie DG, Mi Z, Suzuki F, Jackson EK. Smooth muscle cell-derived adenosine inhibits cell growth. Hypertension. 1996;27(pt 2):766-773.
13. Daly JW, Jacobson KA. Adenosine receptors: selective agonists and antagonists. In: Belardinelli L, Pelleg A, eds. Adenosine and Adenine Nucleotides: From Molecular Biology to Integrative Physiology. Boston. Mass: Kluwer Academic Publishers; 1995:157-166.
14. Geiger JD, Parkinson FE, Kowaluk EA. Regulators of endogenous adenosine levels as therapeutic agents. In: Jacobson KA, Jarvis MF, eds. Purinergic Approaches in Experimental Therapeutics. New York, NY: Wiley-Liss; 1997:55-84.
15. 2b receptor in Xenopus oocytes. Mol Pharmacol. 1993;43: 277-280.
16. 2 receptor subtypes. Mol Pharmacol. 1993;43: 909-914.
17. Jacobson KA, Van Rhee AM. Development of selective purinoceptor agonists and antagonists. In: Jacobson KA, Jarvis MF, eds. Purinergic Approaches in Experimental Therapeutics. New York, NY: Wiley-Liss; 1997:101-128.
18. Farivar RS, Chobanian AV, Brecher P. Salicylate or aspirin inhibits the induction of the inducible nitric oxide synthase in rat cardiac fibroblasts. Circ Res. 1996;78:759-768.
19. Dalziel HH, Westfall DP. Receptors for adenine nucleotides and nucleosides: subclassification, distribution, and molecular characterization. Pharmacol Rev. 1994;46:449-466.
20. Gurden MF, Coates J, Ellis F, Evans B, Foster M, Hornby E, Kennedy I, Martin DP, Strong P, Vardey CJ, Wheeldon A. Functional characterization of three adenosine receptor types. Br J Pharmacol. 1993;109: 693-698.
21. 1 adenosine receptors. FEBS Lett. 1986;209:122-128.
22. 2 binding sites in striatal membranes from mammalian brain. Drug Dev Res. 1988;15:31-46.
23. Dubey RK, Gillespie DG, Mi Z, Jackson EK. Adenosine inhibits growth of human aortic smooth muscle cells via A2B receptors Hypertension. 1998;31:516-521.
24. Dubey RK, Gillespie DG, Mi Z, Jackson EK. Cardiac fibroblasts metabolize cyclic-AMP to generate adenosine. Hypertension. 1996; 28:524. Abstract.
25. Yen MH, Wu CC, Chiou WF. Partially endothelium-dependent vasodilator effect of adenosine in rat aorta. Hypertension. 1988;11:514-518.
26. Vials A, Burnstock G. A2-Purinoceptor-mediated relaxation in the guinea-pig coronary vasculature: a role for nitric oxide. Br J Pharmacol. 1993;109:424-429.
27. Dubey RK, Gillespie DG, Jackson EK. Adenosine induces nitric oxide synthesis in rat aortic smooth muscle cells. Hypertension. 1996;28:552. Abstract.
28. Fujisaki H, Ito H, Hirata Y, Tanaka M, Hata M, Lin M, Adachi S, Akimoto H, Marumo F, Hiroe M. Natriuretic peptides inhibit angiotensin II-induced proliferation of rat cardiac fibroblasts by blocking endothelin-1 gene expression. J Clin Invest. 1995;96:1059-1065.